Overview

Cutaneous B-cell lymphoma is a rare type of non-Hodgkin lymphoma that primarily affects the skin. It develops when B lymphocytes, a type of white blood cell, grow abnormally and accumulate in the skin. Unlike systemic lymphomas, cutaneous B-cell lymphoma often begins in the skin without initial involvement of internal organs. The condition usually progresses slowly, and many forms have a favorable prognosis with appropriate management.

Symptoms

Symptoms of cutaneous B-cell lymphoma mainly involve changes to the skin and may vary depending on the subtype.

Common symptoms include:

  • Painless red, pink, or purple bumps or nodules on the skin

  • Flat or raised skin lesions or plaques

  • Lesions that may appear on the head, neck, trunk, or arms

  • Slow-growing skin tumors

  • Mild itching in some cases

  • Rare ulceration of skin lesions

General symptoms such as fever or weight loss are uncommon in early stages.

Causes

The exact cause of cutaneous B-cell lymphoma is not fully understood. The disease develops due to abnormal growth of B lymphocytes in the skin.

Possible contributing factors include:

  • Acquired genetic mutations in B cells

  • Immune system dysfunction

  • Chronic immune stimulation

  • Certain infections in rare cases

The condition is not contagious and is usually not inherited.

Risk factors

Several factors may increase the risk of developing cutaneous B-cell lymphoma.

Risk factors include:

  • Older age

  • Weakened immune system

  • History of autoimmune disorders

  • Previous lymphoma or blood disorders

  • Male sex, depending on subtype

Most people diagnosed do not have clear identifiable risk factors.

Complications

Cutaneous B-cell lymphoma often remains limited to the skin, but complications can still occur.

Possible complications include:

  • Recurrence of skin lesions after treatment

  • Spread to lymph nodes or internal organs in rare cases

  • Skin infections at lesion sites

  • Cosmetic or psychological impact due to visible lesions

  • Need for long-term monitoring and repeated treatments

Regular follow-up helps detect progression early.

Prevention

There is no known way to prevent cutaneous B-cell lymphoma, as its exact cause is unknown.

General preventive considerations include:

  • Early evaluation of persistent or unexplained skin lesions

  • Regular dermatologic checkups for high-risk individuals

  • Prompt treatment of skin infections

  • Adherence to follow-up and monitoring plans

  • Maintaining overall immune health

Early diagnosis and appropriate care can help manage symptoms and improve long-term outcomes.

Request an appointment

Advertisement

Advertisement